MAM wins Abbot Laboratories PA and media work

Public affairs shop Morgan Allen Moore has won a slice of

pharmaceutical company Abbot Laboratories' PA and media relations


With fees thought to be in six figures, the agency will work on

Respiratory Syncytial Virus (RSV) - a condition that affects 95 to 100

per cent of babies in infancy.

A MAM spokesman said the agency had not been forced to pitch

competitively, but had been through a series of meetings with the client

in recent months.

Three other agencies were involved in this process.

Abbot senior business unit manager Hugh Griffith said: 'We decided to

use a public affairs agency to reach policy makers.'

The agency's brief will have a particular focus on Wales, where there is

a higher incidence of RSV. The agency will lobby government and health

organisations to raise the profile of the condition and its treatments -

including Abbot brand Synagis.

Agency MD Steve Morgan said: 'Having won its second term, the Government

is expanding its relationship with the healthcare sector, presenting

more opportunities for meaningful dialogue and debate.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in